1) HBV-YMDD mutation
![点击朗读](/dictall/images/read.gif)
HBV-YMDD变异
1.
Study on the relation of deficiency syndrome and sufficiency syndrome of TCM in patients with HBV-YMDD mutation;
HBV-YMDD变异患者与中医虚实辨证关系初探
2) Gene mutations(HBV YMDD mutations)
![点击朗读](/dictall/images/read.gif)
基因变异(HBV YMDD变异)
3) YMDD variation
![点击朗读](/dictall/images/read.gif)
YMDD变异
1.
Arab League German luck Wei Zhi treats the YMDD variation the chronic hepatitis B curative effect to forecast the factor clinical research;
阿德福韦酯治疗YMDD变异的慢性乙型肝炎的疗效预测因素临床研究
2.
A study on the disease progression of chronic Hepatitis B with YMDD variation and its clinical management;
YMDD变异后HBeAg(+)患者病情进展及处理的临床研究
3.
The Arab League German luck Wei ester jointly pulls Mi Fu surely to treat the YMDD variation the chronic second grade the hepatitis curative effect correlation factor analysis;
阿德福韦酯联合拉米夫定治疗YMDD变异的慢性乙型肝炎的疗效相关因素分析
4) YMDD mutation
![点击朗读](/dictall/images/read.gif)
YMDD变异
1.
The analysis of YMDD mutation in the antivirus untreated cronic hpatitis B;
![点击朗读](/dictall/images/read.gif)
未经抗病毒治疗的乙型肝炎病人的乙肝病毒YMDD变异分析
2.
Detecting of the hepatic-fibrosis index and serous markers from HBV DNA YMDD mutation of the patients with chronic hepatitis (CH);
慢性乙肝YMDD变异患者肝纤维化指标、血清标志物的检测
3.
Association between YMDD mutation,HBV-DNA determination,ALT level and chronic hepatic B patients with lamivudine;
拉米夫定治疗慢性乙肝患者YMDD变异与HBV-DNA及ALT水平关系
5) YMDD mutations
![点击朗读](/dictall/images/read.gif)
YMDD变异
1.
Objective To assess consistency of the clinical and histopathological diagnosis,and investigate the association of HBV DNA with pathological degree in patients with YMDD mutations of hepatitis B virus(HBV).
目的探讨慢性乙型肝炎发生YMDD变异时临床诊断与病理诊断的符合性,血清HBV DNA与病理分度的关系。
2.
Of all YMDD mutations detected,YIDD variant accounted for 52.
![点击朗读](/dictall/images/read.gif)
目的:调查YMDD变异株在急性HBV感染(AHB)中的流行情况,为指导AHB的防治提供依据。
6) YMDD mutant
![点击朗读](/dictall/images/read.gif)
YMDD变异
1.
Objective To detect HBV YMDD mutant during the process of lamivudine therapy;To study the relationship between the incidence of HBV YMDD mutant and Lamivudine treatment duration,seral HBV DNA level;To detect the variety of seral HBV DNA level during lamivudine therapy.
目的观察拉米夫定治疗慢性乙型肝炎过程中,乙型肝炎病毒(HBV)发生YMDD变异的情况;研究HBVYMDD变异的发生率同拉米夫定用药时间及用药前与血清HBV DNA水平的关系;观察拉米夫定治疗过程中,血清HBV DNA水平的变化。
2.
All these patients′ serums were collected and YMDD mutant was tested by mis matched PCR RFLP,then the relationship was observed among some factors.
方法 4 4例患者来自我科一项临床试验 ,采用聚合酶链反应限制性片段长度多态性 (PCR RFLP)法检测YMDD变异 ,观察两个因素与变异发生的关系。
补充资料:HBV
分子式:
CAS号:
性质:是已知的最小的动物DNA病毒之一,属嗜病毒科。HBV的外形是直径为42nm的球形颗粒,称为戴恩颗粒(Dane particle),有很强的感染性。病毒的最外层是由病毒的表面抗原和脂质构成的外壳,内部是直径27nm,由病毒核心抗原组成的核心颗粒。核心颗粒包裹着病毒DNA基因组和反转录酶。DNA为含一部分单链区的双链DNA分子,长约3.2kb。在乙肝病人血清中,除42nm的病毒颗粒外,还有大量直径为22nm的球形颗粒和一些直径为22nm,长度不等的棒状颗粒,它们只含有表面抗原和脂质,不具感染性。HBV可分为四个主要亚型:adw,adr,ayw,ayr。HBV除引起急性肝炎外,还可引起慢性肝炎和肝硬化。
CAS号:
性质:是已知的最小的动物DNA病毒之一,属嗜病毒科。HBV的外形是直径为42nm的球形颗粒,称为戴恩颗粒(Dane particle),有很强的感染性。病毒的最外层是由病毒的表面抗原和脂质构成的外壳,内部是直径27nm,由病毒核心抗原组成的核心颗粒。核心颗粒包裹着病毒DNA基因组和反转录酶。DNA为含一部分单链区的双链DNA分子,长约3.2kb。在乙肝病人血清中,除42nm的病毒颗粒外,还有大量直径为22nm的球形颗粒和一些直径为22nm,长度不等的棒状颗粒,它们只含有表面抗原和脂质,不具感染性。HBV可分为四个主要亚型:adw,adr,ayw,ayr。HBV除引起急性肝炎外,还可引起慢性肝炎和肝硬化。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条